Should You Buy Biodesix Inc (BDSX) Today? Analysis, Price Targets, and 2026 Outlook.
Analysis Updated At
2026/01/28
Not a good buy right now for a beginner, long-term investor who is impatient. Despite a bullish longer-term moving-average setup and strong gross margins, the stock shows weakening momentum (MACD contracting), a notable down day (-4.96%), insider selling pressure, continued losses with worsening EPS, and the provided pattern-based outlook skews negative over the next month. Better to wait than deploy $50k–$100k here today.
Technical Analysis
Price/Trend: Longer-term trend is constructive with bullish moving averages (SMA_5 > SMA_20 > SMA_200), suggesting the broader structure is up. However, today’s regular-session drop (-4.96%) signals near-term volatility and potential pullback behavior.
Momentum: MACD histogram is positive (0.408) but positively contracting, which often indicates bullish momentum is fading rather than accelerating.
RSI: RSI_6 at 64.53 is neutral-to-slightly-warm (not overbought), but not a strong fresh buy signal.
Levels: Pivot ~9.94 is the key near-term line; holding above it supports the bullish structure. Resistance sits around R1 ~12.02 (then ~13.30). Support levels are ~7.86 (S1) and ~6.58 (S2).
Near-term odds (provided): Similar-pattern projection implies weakness ahead (50% chance to -7.89% over the next month), which argues against buying immediately if you don’t want to wait for a better entry.